Main therapies to reduce stress and anxiety

MM120 has FDA Breakthrough Therapy designation and is in Phase 3 clinical trials, showing significant improvement in anxiety symptoms after a single dose. If approved, it may become the first psychedelic-derived treatment for GAD, offering a fast-acting and long-lasting option.

CBT remains the 'gold standard' for treating anxiety, panic, and phobias, showing lasting improvements across numerous mental health conditions. It is a structured, goal-oriented therapy that helps individuals identify and change negative thought patterns and behaviors.

DBT is highly effective for emotion dysregulation, anxiety, and high-stress careers, teaching crucial skills in mindfulness, distress tolerance, emotion regulation, and interpersonal effectiveness. It continues to be a sought-after modality for managing intense emotional responses.

ACT is highly effective for chronic stress, burnout, and for professionals feeling 'stuck,' as it focuses on psychological flexibility and values-based living. It helps reduce avoidance behaviors and build resilience by teaching acceptance of difficult emotions.

EMDR remains the 'gold standard' for trauma treatment and is recognized for significantly reducing PTSD symptoms, often more rapidly than other therapies. While primarily for trauma, it is also effective for anxiety by helping process distressing memories.

These therapies are gaining clinical traction for addressing nervous system dysregulation that persists despite cognitive insight, especially for individuals with trauma histories, anxiety disorders, and chronic stress. They focus on the autonomic nervous system's role in safety and survival responses.

IFS has 'exploded in popularity' and shows promise for chronic pain, depression, and PTSD in peer-reviewed research. It views the mind as being made up of various 'parts' and aims to heal wounded parts to bring the self into leadership.

Exposure-Based Therapies are more streamlined and supported with digital tools, empowering individuals in their treatment, especially for social and phobic anxiety. They involve gradually exposing individuals to anxiety-provoking situations in a safe environment.

Sleep plays a major role in managing stress, and poor sleep amplifies it, making quality sleep crucial for overall well-being. Establishing consistent routines and a conducive environment enhances the ability to handle daily pressures.

Engaging in regular physical activity releases endorphins, reduces cortisol, and improves blood flow to the brain, significantly reducing perceived stress. Mindful movement practices like yoga also enhance body-mind connection and relaxation.

Mindfulness and meditation effectively lower anxiety, improve emotional regulation, and reduce cortisol levels by keeping individuals grounded in the present moment. These practices are crucial for proactive stress management and overall well-being.

Deep breathing exercises activate the body's relaxation response, lower heart rate, and reduce cortisol levels quickly. Techniques like the 4-7-8 method are simple yet powerful tools for immediate stress relief.

Journaling helps process emotions, recognize stress triggers, and reduces anxiety symptoms by providing an outlet for thoughts and feelings. Gratitude journaling specifically rewires the brain toward positivity, enhancing overall well-being.

Strong social ties buffer against stress, release mood-lifting hormones, and combat loneliness, making connection with others a vital component of stress reduction. Talking to friends, family, or support groups provides essential emotional support.

Personalized medication plans, often using pharmacogenomic testing, tailor treatment to an individual's unique biology, reducing trial-and-error and offering modern options with potentially fewer side effects. This approach is far more precise in 2026.

Ketamine therapy can rapidly relieve symptoms for people with treatment-resistant anxiety or co-occurring depression, influencing the glutamate system and supporting neural growth. It remains an important FDA-approved option for difficult-to-treat conditions.

Psilocybin therapy is nearing FDA approval and shows significant reductions in depression severity in clinical trials, often co-occurring with anxiety. It is positioned as the most likely next psychedelic to gain federal approval, offering a new option for those with treatment-resistant conditions.